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Erythropoietin (Epo) and interleukin-3 (IL-3) stimulate activation of the Jak2 tyrosine kinase and induce tyrosine phosphorylation and activation of Stat5. In the present study, we have shown that Epo or IL-3 stimulation induces binding of Stat5 to the tyrosine-phosphorylated Epo receptor (EpoR) or IL-3 receptor subunit (PIL3), respectively, in IL-3-dependent 32D cells expressing the EpoR. The binding of Stat5 t o these cytokine receptors was shown t o be rapid and transient, occurring within 1 minute of stimulation of cells and significantly decreasing after 5 minutes of cell treatment. In vivo binding experiments in COS cells showed that binding of Stat5 to the EpoR was mediated through the Stat5 Src homology 2 (SH2) domain. In vitro binding studies further showed that Stat5, but not other Stats examined, bound specifically t o tyrosine-phosphorylated recombinant EpoR fusion proteins. In these in vivo and in vitro binding studies, Stat5 bound, albeit t o a lesser degree, t o truncated EpoR mutants in which all the intracellular tyrosines except V-343 HE GROWTH AND differentiation of hematopoietic cells are regulated through the interaction of several hematopoietic growth factors, including erythropoietin (Epo) and interleukin-3 (IL-3), with their specific cell surface receptors, which belong to the cytokine receptor superfamily and lack intrinsic tyrosine kinase activity.'.' However, the cytokine receptors have been shown to activate the Jak family of tyrosine kinases, which physically associate with the membrane proximal domain of the receptors containing the It has been hypothesized, although still largely unproved, that activated cytokine receptors recruit specific Stats through the interaction between specific sites of tyrosine phosphorylation in the receptor cytoplasmic region and the Src homology 2 (SH2) domain, a conserved modular domain that binds to phosphotyrosine-containing sequences, of Stats."' The recruited Stats would then be phosphorylated by the activated Jaks and dissociate from the receptor to form homodimers or heterodimers through reciprocal SH2 domain-phosphotyrosine interactions. Dimerized Stats are translocated to the nucleus and activate target genes by binding to specific regulatory sequences. Specificity of activation of Stats would be thus controlled not by Jaks but by the ability of activated and tyrosine-phosphorylated receptors to recruit specific Stats. This scenario is indirectly supported by various experimental observations. For instance, swapping of the SH2 domains of Statl and Stat2 was shown to change the receptors by which the chimeric molecules are activated.' It was also shown that a YXXQ consensus sequence is required for activation of Stat3 by the gp130 component of the IL-6 receptor family and that transfer of this motif to the Epo receptor (EpoR) endowed the mutant recep- were removed. Furthermore, EpoR-derived synthetic phosphotyrosine peptides corresponding t o V-343, V-401, Y-43'1. and V479 inhibited the in vitro binding of Stat5. When expressed in 32D cells, a mutant EpoR in which alt the intracellular tyrosines were removed by carboxy-terminal truncation showed a significantly impaired ability t o induce tyrosine phosphorylation of Stat5, particularly at low concentrations of Epo, but exhibited an increased sensitivity to Epo for growth signaling as compared with the wild-type EpoR. These results indicate that Stat5 specifically and transiently binds to the EpoR through the interaction between the Stat5 SH2 domain and specific phosphorylated tyrosines, including V-343, in the EpoR cytoplasmic domain. It was implied that PIU may also have similar Stat5 docking sites. The Stat5 docking sites in the EpoR were shown t o facilitate specific activation of Stat5, which, however, may not be required for the EpoR-mediated growth signaling. 0 1996 by The American Society of Hematoiogy.
tor with the ability to activate Stat3.' Furthermore, synthetic tyrosine phosphopeptides derived from the receptors for interferon-y (IFNy),9,'0 interferon-a (IFNa)," IL-4,".'* IL-2,".14 and IL-7I3 have been shown to disrupt activated Stat inhibit Stat activation in permeabilized cells,' ." or bind Stats in ~i t r o .~" ' Nevertheless, for most of the cytokine receptors, binding of Stats in vivo has not been shown; exceptions include binding of Stat3 to gp130l5 or to the IFNa receptor" and binding of Stat2 to the IFNa receptor," which were ligand-dependent but stable after ligand stimulation.
The receptor for IL-3 (IL3R) consists of the a and p subunits, both of which belong to the cytokine receptor superfamily.'* The mouse has two highly homologous , B subunits, /?c and &, whereas the human has only one type of of cellular protein^.^*-'' Recent studies further showed that Epo and IL-3 induce tyrosine phosphorylation and activation of Stat5,2'-32 which was initially purified and cloned as a mediator of prolactin-induced transcription of the @casein gene.33 Two murine homologues, Stat5A and StatSB, sharing 96% amino acid sequence identity, have been identified, although no functional differences have yet been observed between these two molecules.*' A variety of other cytokines, including growth hormone, granulocyte-macrophage colonystimulating factor (GM-CSF), IL-5, IL-2, and thrombopoietin, have also been shown to activate Stat5.28~"~".34" 7 Mui et a12' previously reported that tyrosine residues in the intracellular region of the pc component of the human IL-3WGM-CSF receptor were not required for induction of tyrosine phosphorylation and activation of Stat5.
On the other hand, very recent s t~d i e s~* -~'
showed that Y-343, based on nomenclature for the mature protein, of the EpoR plays an essential role in Stat5 activation, because mutations of this tyrosine in truncated EpoR mutants that had lost all the other tyrosine residues significantly diminished or eliminated the ability of the receptors to activate Stat5. Furthermore, synthetic tyrosine phosphopeptides derived from the EpoR sequence containing Y-343 disrupted Stat5 DNA binding a~tivity.~"'~ It was thus proposed that Y-343 and other tyrosines in the EpoR cytoplasmic region may function as StatS docking sites. However, in these studies, binding of Stat5 with the EpoR was not shown. Therefore, the exact mechanisms by which Stat5 specifically interacts with the EpoR to become tyrosine phosphorylated and activated by Jak2 have remained elusive. In addition, a possible role Stat5 may play in transducing a growth signal from the EpoR has remained controversial, because conflicting results were reported in these st~dies.'*~~"
In the present study, we provide the first direct evidence that Stat5 binds to the receptors for Epo and IL-3 after ligand stimulation. We further investigated the mechanisms of interaction of Stat5 with the EpoR and also evaluated the significance of the Stat5 binding on Epo-induced StatS phosphorylation and growth signaling.
MATERIALS AND METHODS
Cells and reagents. IL-3-dependent 32D cell clones that express equivalent numbers, as determined by '2SI-Epo binding assays, of the wild-type EpoR and the truncated S-mutant EpoR were previously described4' and maintained in RPM1 1640 medium supplemented with 10% fetal calf serum (FCS) and 10% WEHI-3 conditioned medium as a source of IL-3. Recombinant human Epo was kindly provided by Chugai Pharmaceutical CO Ltd (Tokyo, Japan). Recombinant murine IL-3 was purchased from PeproTech lnc (Rocky Hill, NJ). COS-7 cells were cultured in Dulbecco's modified Eagle medium supplemented with 10% FCS.
Expression plasmids for the murine wild-type or truncated E~O R S , '~,~* the murine StatSA cDNA," and EpoR-derived synthetic pho~phopeptides"~~~ were described previously. An eukaryotic expression vector, P J~M ,~~ was obtained from American Type Culture Collection (Rockville, MD).
A rabbit antiserum raised against a glutathione S-transferase (GST) fusion protein containing amino acids 257 to 441 of the EpoR cytoplasmic domain was described previously.u Rabbit antisera against Jak2, Stat3, Stat4, Stat5A, and Stat6 were also described previoUs~y.24.~Y.4S. 46 Rabbit antibodies against StatSB and pI1.l (K-l 9) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal antibodies against phosphotyrosine (4GIO), c-Myc (9EIO), and Stat1 were purchased from Upstate Biotechnology, Inc (Lake Placid, NY), Berkeley Antibody CO (Richmond, CA), and Transduction Laboratories (Lexington, KY), respectively.
Immunoprecipitation and immunoblotting. Cells were washed free of IL-3, cultured overnight, and left unstimulated as a negative control or stimulated with Epo or IL-3 at a saturating concentration, unless otherwise described. Cells were solubilized at 4 x IO7 cells/ mL with lysis buffer composed of 1 % Triton X-100, 20 mmol/L Tris-HCI (pH 7S), IS0 mmol/L NaCl, 1 mmollL EDTA, I mmol/ L sodium orthovanadate, I mmollL phenylmethylsulfonyl fluoride (PMSF), I O &nL aprotinin, and 10 pglmL leupeptin. Cell lysates were subjected to immunoprecipitation as described p r e v i o~s l y .~~ For immunoblot analysis of total cell lysates, aliquots of the clarified supernatant were directly mixed with equal volumes of 2 x Laemmli's sample buffer and heated at 100°C for S minutes. Samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred to Immobilon P membranes (Millipore, Bedford, MA). The membranes were probed with a relevant antibody followed by detection using enhanced chemiluminescence Western blotting detection system (Amersham, Buckinghamshire, UK). For reprobing of the membranes, they were treated with stripping buffer composed of 100 mmol/L 2-mercaptoethanol, 2% SDS, and 62.5 mmollL Tris-HCI (pH 6.7) at S O T for 30 minutes and subsequently probed with a different antibody.
Transient expressinn in COS-7 cells. For construction 01 an expression plasmid for the StatS SH2 domain, a portion of the murine StatSA cDNA coding for amino acids S89 to 677 was amplified by the polymerase chain reaction (PCR) using S' and 3' primers of 5'-CCGGATCC TGGAATGATGGGGCTATCCT-3' and 5"CCGAAT-TCACTCGTCCTTGGGTCGGTCT-3'. respectively. The primer sequences were designed to add the BamHI and EcoRl recognition sequences at the S' and 3' ends, respectively, of the amplified fragment. These sites were then used for directional subcloning of the amplified fragment into an expression plasmid, pJ3M, which is designed to add an epitope tag from c-Myc to the N-terminus of protein expressed."
Transfection of expression plasmids into COS-7 cells was performed using the Lipofectamin reagent (GIBCO-BRL. Grand Island. NY) according to the manufacturer's instructions. Two days after transfection, cells were stimulated with Epo or left unstimulated, solubilized, and subjected to immunoprecipitation and immunobiotring as described above.
Preparation .f t4'r[Jsine-pho.~pho~lated GST-EpoK recombinant proteins and in vitro binding as,say.s. Bacterial expression plasmids coding for GST fusion proteins containing the cytoplasmic domains of the wild-type and S-mutant EpoRs were generated by subcloning the Bgl 11-EcoR1 fragments from the eukaryotic expression vectors pXM-EpoR and pXM-EpoR-S, respectively, into the B u~H I -E~o R I site of pGEX-3 (Pharmacia, Uppsala, Sweden). To generate an expression plasmid for GST-fusion protein containing the cytoplasmic EpoR domain lacking 42 or 9 I amino acids from the carboxy terminus, truncated mutant EpoR cDNAs were generated by the PCR method using 3' primers with a stop codon inserted at the indicated site and subcloned into the pXM vector, as described." The Bgf IIEcoRl fragments from these plasmids were then subcloned into the BamHI-EcoRl site of pGEX-3.
To prepare tyrosine-phosphorylated or unphosphorylated GSTEpoR fusion proteins, bacterial expression plasmids were trdnsformed into Epicurian Coli' TKXI competent cells (Stratagene, La Jolla, CA), which harbor a plasmid-encoded Elk tyrosine kinase gene controlled under the trp promoter, and recombinant proteins were prepared according to the manufacturer's instructions. In brief, GST-EpoR fusion proteins were produced in Escherichia c o l i by isopropyl-P-D-thio-galactopyranoside induction and were purified For personal use only. on October 3, 2017. by guest www.bloodjournal.org From on a large scale by affinity chromatography on glutathione-Sepharose beads (Pharmacia). To prepare tyrosine-phosphorylated fusion proteins, Ecoli cells were further cultivated for 2 hours in Trp starvation medium in the presence of indoleacrylic acid to induce expression of the Elk tyrosine kinase. Purified proteins were resolved by SDS-PAGE and subjected to evaluation with Coomassie Blue staining or antiphosphotyrosine blotting.
In vitro binding of various Stat proteins to the GST-EpoR fusion proteins was examined essentially as described previously.' ' In brief, 32D/EpoR-Wt cells were lysed in the lysis buffer described above at 2 X IO' cellslml. Lysates were mixed with I pg of GST fusion proteins on glutathione-Sepharose beads and incubated at 4°C for 2 hours. After being washed three times with the lysis buffer, proteins bound to the beads were eluted by boiling in Laemmli's SDS sample buffer and examined by immunoblotting with antibodies against various Stat proteins. For competition of Stat5 binding to EpoR with EpoR-derived phosphotyrosine peptides, cell lysates were incubated for 2 hours at 4°C with 200 pmol/L or the indicated concentrations of a synthetic peptide before incubation with beads containing the tyrosine-phosphorylated wild-type EpoR fusion protein.
Cellgrowth assay. For measurement of the cell number increase, cells were seeded into a 96-well plate at a density of I X IOS/mL in 10% FCS-containing RPM1 1640 Because the two tyrosine-phosphorylated proteins found to associate with Stat5 corresponded in size to the EpoR and PIL3. we then directly examined the physical association of Stat5 with these receptors using specific antibodies. As shown in Fig 2A, 32DEpoR -Wt cells were stimulated with Epo for the various periods indicated and Stat5 was immunoprecipitated with antibody reactive with Stat5B. Antiphosphotyrosine immunoblotting of the immunoprecipitates showed that Stat5-associated pp72 was most conspicuous in cells stimulated for 1 minute and gradually became fainter thereafter. Immunoblotting with anti-EpoR showed that the tyrosine-phosphorylated 72-kD form of EpoR, which corresponds to only a small fraction of the whole E~O R ,~~. '~ physically associated with Stat5 and comigrated with pp72. The association of Stat5 with the EpoR was dependent on Epo stimulation, peaked at I minute after stimulation, and became barely detectable after 10 
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. which peaked at 1 minute after stimulation. Slower migration of StatSB, run on a 5% gel, was conspicuously observed at 5 or 30 minutes after IL-3 stimulation and corresponded to a prominent tyrosine phosphorylation of Stat5 observed at these times. For the results shown in Fig 2A and B, comparable results were also observed by using antiStat5A (data not shown).
The SH2 domain of Stat5 is involved in binding to the EpoR. To further explore the mechanisms of Stat5 binding to the EpoR, we then examined whether the Stat5 SH2 domain is involved in binding to the tyrosine-phosphorylated EpoR, because it has been established that a variety of intra- --a -aStat5B 97-m ' * *-P cellular signaling molecules bind through their SH2 domains to tyrosine-phosphorylated receptors for various growth factors and cytokines." For this purpose, we expressed the Stat5 SH2 domain, which was tagged with a c-Myc epitope, in COS-7 cells and examined its physical association with coexpressed EpoR or its truncated mutants (Fig 3A) by antiMyc immunoblotting of anti-EpoR immunoprecipitates. As shown in Fig 3B, the association of the Stat5 SH2 domain with the wild-type EpoR was barely detectable when only these two proteins were expressed in COS cells. However. the association increased significantly when the Jak2 kinase was coexpressed, with a further increase in binding observed when cells were stimulated with Epo. The StatS SH2 domain also bound to the truncated H mutant, which retained Y-343 as the only one tyrosine in the intracellular domain when the mutant was expressed with Jak2. In contrast, the Stat5 SH2 domain failed to associate with the further truncated S mutant, in which all the intracellular tyrosines were removed. Reprobing of the membrane with anti-EpoR antibody confirmed that the wild-type EpoR and the mutants were expressed at comparable levels ( Fig 3B) . Further reprobing with antiphosphotyrosine antibody showed that the wild-type EpoR was constitutively tyrosine phosphorylated, whereas the tyrosine phosphorylation of the two mutants was not detectable (Fig 3B) . These results indicate that the Stat5 SH2 domain is involved in binding with the EpoR. However, it remained to be determined whether the phosphorylated tyrosine residues in the EpoR cytoplasmic region are also involved in the binding, because the tyrosine phosphorylation status of the wild-type EpoR or the H mutant, as examined by antiphosphotyrosine blotting, did not correlate with the binding of the Stat5 SH2 domain in COS cells.
Involvement of phosphorylated tyosine residues in the EpoR cytoplasmic domain in binding with Stat5 To examine whether phosphorylated tyrosine residues in the EpoR cytoplasmic domain are required for binding with Stat5, we prepared tyrosine-phosphorylated GST-EpoR fusion proteins ( Fig 4A) by coexpressing the Elk tyrosine kinase with these fusion proteins in E coli, as described in the Materials and Methods. The tyrosine-phosphorylated and unphosphorylated fusion proteins, bound to glutathione Sepharose beads, were then used for in vitro binding assays with Stat5 and other Stat proteins in cell lysates. As shown in Fig 4B, Statl, Stat3, Stat4, or Stat6 failed to associate with the fusion proteins, irrespective of their tyrosine phosphorylation status. Stat5A and StatSB, on the other hand, specifically bound to the tyrosine-phosphorylated forms of GST-EpoR fusion proteins. Importantly, binding of Stat5A and StatSB was observed, albeit to a lesser extent, with an GST-EpoR protein (-91) in which the carboxy-terminal91 amino acids, including all the tyrosine residues except for Y-343, were removed by truncation. These results indicate that the phosphorylation of Y-343 or other tyrosines in the EpoR cytoplasmic domain is required for specific binding with Stat5. In accordance with the failure of other Stats to associate with the EpoR, antiphosphotyrosine blotting of immunoprecipitates obtained with specific antibodies failed to detect any tyrosine phosphorylation of these Stats in 32DEpoR cells stimulated with Epo for 1 minute (data not shown). This implies that the specificity of Stat activation by EpoR depends on the specific recruitment of Stat5 to the phosphotyrosines in the EpoR cytoplasmic domain.
To define tyrosine residues in the EpoR that are involved in binding of Stat5, in vitro binding competition assays were performed using synthetic phosphopeptides corresponding to the potential phosphorylation sites of the EpoR (Table I) . Cell lysates from 32DEpoR-Wt cells were incubated with each of these phosphopeptides and subsequently subjected to the in vitro binding assay with the tyrosine-phosphorylated GST-EpoR-Wt protein. As shown in Fig 4C, (Fig 4D) . Densitometric scanning of immunoblots showed that the Y-479 peptide most efficiently inhibited the binding, whereas the Y-401 peptide was least effective ( Table I) .
Epo-induced Stat5 phosphorylation and cell growth in 320 cells expressing n mutant EpoR that lacks the Stat5 docking sites. To explore the significance of Stat5 docking sites of the EpoR, we examined the Epo dose response of tyrosine phosphorylation of Stat5 in 32DEpoR-S, a clone of 32D cells expressing the S-mutant EpoR in which all the 8 tyrosine residues were removed by carboxy-terminal truncation of 145 amino acids ( Fig 3A) . As shown in Fig  5A, tyrosine phosphorylation of Stat5 was readily detectable in 32DEpoR-Wt cells stimulated with 0.01 U/mL of Epo. In contrast, Epo-induced Stat5 phosphorylation in 32DEpoR-S cells was hardly discernible when stimulated with a dose as high as I U/mL of Epo, although it was observed at an almost comparable level with that in 32DEpoR-Wt at 100 U/mL of Epo. The ability of the S-mutant EpoR to induce
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tyrosine phosphorylation of Stat5 was thus impaired most significantly when stimulated at low concentrations of Epo. On the other hand, Epo-induced tyrosine phosphorylation of Jak2 was comparably observed in 32DEpoR-Wt or 32D/ EpoR-S when stimulated at I O to 1 0 0 U/mL of Epo. These results indicate that the recruitment of Stat5 to the tyrosinephosphorylated EpoR may be required for tyrosine phosphorylation of Stat5 at physiological concentrations of Epo, whereas Jak2 may directly interact and phosphorylate Stat5 when prominently autophosphorylated by stimulation with higher concentrations of Epo.
To evaluate a possible role that Stat5 may play in the EpoR-mediated growth signaling, we next compared the Epo dose responses of proliferation of 32DEpoR-Wt and 32D/ EpoR-S. As shown in Fig 5B, 32DEpoR -S exhibited an increased sensitivity to Epo as compared with 32DEpoR-Wt and proliferated significantly in response to as low as IO mU/mL of Epo. This is in agreement with previous studies that showed the hypersensitivity of various truncated EpoR mutants to Epo in BaF3 and 32D cell lines.JX.52.s3 Because Epo-induced tyrosine phosphorylation of Stat5 was distinctly diminished and hardly discernible in 32DEpoR-S stimulated at IO to 100 mU/mL of Epo, the increased mitogenic response of 32DIEpoR-S as compared with 32DEpoR-Wt at For . . phosphorylated cytokine receptors through the SH2 domain and, after phosphorylated by Jaks, rapidly dissociate from the receptor to form homodimers or heterodimers through reciprocal SH2 domain-phosphotyrosine interactions (Fig In vivo binding studies in COS cells showed that the StatS SH2 domain is involved in binding with the EpoR. In vitro binding studies using GST-EpoR fusion proteins further showed that tyrosine phosphorylation of the EpoR cytoplasmic region is required for binding with StatS. Importantly, other Stats examined. including Statl, Stat3, Stat4. and Stat6, failed to associate with the tyrosine-phosphorylated GST-EpoR. Because none of these Stats was tyrosine phosphorylated in Epo-stimulated cells (data not shown), specific binding of StatS to the tyrosine-phosphorylated GST-EpoR proteins support the idea that the specificity of Stat activation by cytokine receptors is dependent on the specific interaction between the Stat SH2 domains and the phosphotyrosine sequences in cytokine receptor cytoplasmic regions.
Competition studies using synthetic tyrosine phosphopeptides derived from possible tyrosine phosphorylation sites in the EpoR further showed that Y-343, Y-401, Y431, and Y- (Fig 3B) . Furthermore, another truncated EpoR that also retains only Y-343 bound StatS in vitro when tyrosine phosphorylated (Fig 4B) . In accordance with these results indicating that Y-343 should play a role in binding with StatS, previous studies showed that this tyrosine residue plays an important role in activation of StatS, because substitutions of Y-343 in the context of truncated EpoRs retaining only this tyrosine severely impaired or abrogated the ability of the receptors to activate StatS.'"~"" In these studies, EpoR-derived tyrosine-phosphorylated peptides containing Y-343 also disrupted the DNA binding activity of activated StatS dim er."^"' However, it should be noted that Epo-induced phosphorylation of Y-343 has not been observed in previous studies".lX"'i or in the present study (Fig 3B) . although a truncated EpoR retaining only Y-343 was tyrosine phosphorylated when expressed in Sf9 cells using a baculovirus vectorSJ or when coexpressed with the Elk tyrosine kinase in E coli (data not shown). It is thus possible that phosphorylated Y-343 may be highly susceptible to protein tyrosine phosphatases in mammalian cells. In accordance with this idea. the tyrosine phosphorylation of the H-mutant EpoR was observed in COS transfectants pretreated with a tyrosine phosphatase inhibitor, pervanadate, before Epo stimulation (H.C.. N.N.. and O.M., unpublished observation).
The other three tyrosine residues shown to inhibit StatS binding to the EpoR in the present study were also implicated in EpoR-mediated activation of StatS in previous studies. Using the same synthetic phosphopeptides used in this study, Quelle et aI3" reported that the phosphopeptide containing Y-43 I or Y-479 disrupted the DNA binding activity of activated StatS dimer. On the other hand, using different synthetic peptides, Gobert et al'" showed that a phosphopeptide containing Y-401 efficiently inhibited DNA binding activity of StatS, whereas that containing Y-431 showed only a partial inhibitory effect. In the present study, the Y-479 phosphopeptide most efficiently inhibited StatS binding to the EpoR, whereas the Y-401 phosphopeptide exhibited the most inefficient inhibitory activity among the four peptides, as judged by the concentrations of phosphopeptides required to reduce the StatS binding by half (Table l ). The differences in the synthetic peptides used or the assay systems employed may be responsible for the discrepancies observed. In this regard. it should be noted that the Elk-induced tyrosine phosphorylation pattern of the GST-EpoR fusion protein may be different from the Jak2-induced phosphorylation pattern of endogenous EpoRs in erythroid progenitors. Gobert et al"" also showed that Y-401 plays a role in EpoR-mediated activation of StatS by using a mutant receptor having Y-401 as the sole tyrosine residue in the cytoplasmic region, whereas Y-431 was found to have a marginal effect on StatS activation. However, it is noteworthy that the amino acids follow- The functional significance of the Stat5 docking sites on Stat5 activation was shown by the truncated S-mutant EpoR, in which all the intracellular tyrosine residues were removed by carboxy-terminal truncation, because this mutant exhibited a severely impaired ability to induce tyrosine phosphorylation of Stat5 (Fig 5A) . The impairment was most significant at low Epo concentrations, whereas the tyrosine phosphorylation of Stat5 was readily detectable in the mutant-expressing cells stimulated at higher Epo concentrations. These observations are consistent with those of previous studies on a mutant EpoR in which all eight of the intracellular tyrosines of EpoR were mutated3' or the seven carboxy-terminal tyrosines were removed by truncation and Y-343 was m~tated.~'.~' Because the association of Stat5 with the truncated EpoR was undetectable in vitro (Fig 4B) or in vivo (data not shown), as expected from the absence of all the Stat5 docking sites, induction of tyrosine phosphorylation of Stat5 at high concentrations of Epo might have been mediated through a direct interaction between Stat5 and Jak2, which was conspicuously tyrosine phosphorylated at high concentrations of Epo (Fig 5A) . This is in accordance with our previous study in which an epidermal growth factor (EGF) receptodJak2 tyrosine kinase domain chimera induced EGF-dependent tyrosine phosphorylation of Stat5 without activating any cytokine receptor^.'^ Taken together, these observations indicate that the Stat5 docking sites of the EpoR may function to facilitate Stat5 activation at physiological concentrations of Epo, whereas Stat5 may be also activated through direct binding and phosphorylation by Jak2 when cells were stimulated at higher concentrations of Epo.
In previous st~dies,~*-~' conflicting results have been reported on whether activation of Stat5 may play a role in the EpoR-mediated growth signaling. Using IL-3-dependent DA3 cells expressing a truncated EpoR mutant in which the only one remaining tyrosine residue, Y-434, was mutated, Quelle et a139 reported that the impairment in Stat5 activating ability did not affect the ability of the mutant to transduce a mitogenic signal. This suggested that Epo-induced activation of Stat5 may not play a role in growth signaling from the EpoR. In apparent contradiction to this report, Damen et a13' showed, also using the DA3 cells, that the impairment in Stat5 activating abilities of mutant EpoRs in which all the intracellular tyrosines were mutated or removed by carboxyterminal deletion correlated with the impairment in mitogenic abilities. It was thus suggested that Stat5 may play a role in the EpoR-mediated growth signaling. In accordance with this finding, Gobert et a14' observed, in IL-3-dependent FDCP-l cells, a decrease in mitogenic ability of a mutant EpoR that is quite similar to the mutant EpoR that Quelle et a13' examined in DA3 cells. It has thus remained to be determined whether Stat5 may play a role in growth signaling from the EpoR or what accounted for these conflicting results. It should also be noted that truncated EpoR mutants expressed in the DA3 cell line, which was used in the former two st~dies,~'*~' do not exhibit hypersensitivity to Epo, which has been observed when these mutant EpoRs were expressed in other IL-3-dependent cell lines such as BAF3 or 32D.48,52.s3 Based on the Epo hypersensitivity observed in these cell lines, it has been postulated that the carboxyterminal region of EpoR has an inhibitory effect in growth ~ignaling.~l~~* This effect should play a physiologically important role in the growth control of erythroid progenitor cells, because truncated EpoRs have been shown to cause hereditary erythro~ytosis.~'.~~ Because the failure to observe this inhibitory effect in DA3 cells implies that the EpoRmediated growth signaling in DA3 cells may be modulated differently from that in the erythroid progenitors, the effect of Stat5 activation on the EpoR-mediated growth signaling observed in DA3 cells may not be physiologically relevant.
In the present study, a clone of 32D cells expressing the S-mutant EpoR, impaired in its ability to activate Stat5 due to the absence of Stat5 docking sites, exhibited an increased sensitivity to Epo for proliferation as compared with the wild-type EpoR-expressing cells (Fig 5B) . This finding is consistent with the previous observation that the caroboxy terminal region of EpoR has the inhibitory effect on growth ~i g n a l i n g ,~~,~' as described above. Recent studies suggested that this inhibitory effect may be caused, at least in part, by the recruitment of hematopoietic cell phosphatase (HCP), which dephosphorylates and thus inactivates Jak2, to the tyrosine-phosphorylated carboxy-terminal region of the EpoR through interaction with the HCP SH2 region.4z3sz However, notably, the hypersensitivity of the S-mutant EpoR to Epo was most distinctly observed at Epo concentrations of 10 to 100 mU/mL, at which the impairment in Stat5 activation was also most significant (Fig 5) . It is thus possible that Stat5 may play an inhibitory role in the EpoR-mediated growth signaling. In this regard, it should be noted that Stat5 regulates the transcriptional activation of cis,",57 which may have a negative regulatory role in cell growth.'' Intriguingly, growth inhibitory roles have recently been reported for other Stats, such as Statl" or Stat3.6036' Alternatively, the absence of Stat5 activation might have been compensated by other downstream signaling pathways from the EpoR, even though Stat5 could play a roll in growth signaling. Consistent with this possibility, Mui et aIs7 very recently reported a partial inhibitory effect of a dominant negative Stat5 mutant on cell growth induced with high concentrations of IL-3, thus suggesting that Stat5 activation is required for a maximal proliferative response. Further studies on the downstream signaling pathways, particularly on the one leading to the induction of c-myc expression that is not regulated by Stat5,3'.57 are required to elucidate the exact mechanisms by which the growth of hematopoietic cells are regulated by activated cytokine receptors. (Fig 2B) , which is quite similar to that with the EpoR, strongly suggests that ,BIL3 may also have similar Stat5 docking sites. We also observed that the tyrosine-phosphorylated 140-kD protein (pp140), corresponding in size to Pc, associated with Stat5 in GM-CSF-stimulated human cell lines, UT-7 and TF-l (H.C., N.N., and O.M., unpublished observation), thus suggesting that Stat5 may also interact with the The time course of physical association of Stat5 with For personal use only. on October 3, 2017. by guest www.bloodjournal.org From human p c subunit. However, this is inconsistent with the previous observation that tyrosine residues in the p c cytoplasmic region of the human IL-3 and GM-CSF receptors were not required for activation of Stat5, although the dose response of GM-CSF-induced Stat5 activation was apparently not examined.'' Further studies on the physical and functional interactions of Stat5 with the IL-3 and GM-CSF receptors are under way in our laboratory to elucidate the mechanisms of Stat5 activation by these receptors.
